Health-related quality of life in chronic HCV-infected patients switching to pegylated-interferon-free regimens (ARNS CO20 CUPIC cohort study and SIRIUS trial)
ContributorsCarrieri, Maria Patrizia; Protopopescu, Camelia; Younossi, Zobair; Vilotitch, Antoine; Fontaine, Hélène; Petrov-Sanchez, Ventzislava; Marcellin, Fabienne; Carrat, Fabrice; Hézode, Christophe; Bourlière, Marc; CUPIC study group
CollaboratorsNegro, Francesco
Published inThe Patient - Patient-Centered Outcomes Research, vol. 10, no. 5, p. 605-614
Publication date2017
Abstract
Keywords
- Age Factors
- Aged
- Antiviral Agents/administration & dosage/adverse effects/therapeutic use
- Benzimidazoles/administration & dosage/adverse effects/therapeutic use
- Cohort Studies
- Comorbidity
- Double-Blind Method
- Female
- Fluorenes/administration & dosage/adverse effects/therapeutic use
- Health Status
- Hepatitis C
- Chronic/drug therapy/psychology
- Humans
- Male
- Mental Health
- Middle Aged
- Oligopeptides/therapeutic use
- Patient Reported Outcome Measures
- Polyethylene Glycols
- Proline/analogs & derivatives/therapeutic use
- Quality of Life
- Severity of Illness Index
- Sex Factors
- Sustained Virologic Response
- Uridine Monophosphate/administration & dosage/adverse effects/analogs & derivatives/therapeutic use
Affiliation entities
Research groups
Citation (ISO format)
CARRIERI, Maria Patrizia et al. Health-related quality of life in chronic HCV-infected patients switching to pegylated-interferon-free regimens (ARNS CO20 CUPIC cohort study and SIRIUS trial). In: The Patient - Patient-Centered Outcomes Research, 2017, vol. 10, n° 5, p. 605–614. doi: 10.1007/s40271-017-0232-1
Main files (1)
Article (Published version)
Identifiers
- PID : unige:125977
- DOI : 10.1007/s40271-017-0232-1
- PMID : 28353221
Journal ISSN1178-1653
